🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Glaukos Corporation

GKOS Healthcare
$233.04 $-5.57 (-2.33%)
Market Cap: $13.79 B
Gurus Holding
6
Popularity Rank
#1486
% of Shares Held
0.53%
Net Activity (Q2 2026)
+$10.97 M

Guru Ownership Trend

Guru Analysis for Glaukos Corporation (GKOS)

Glaukos Corporation (GKOS), a key player in the Healthcare sector, continues to attract institutional attention.

As of Q2 2026, a total of 6 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $73.71 M.

Top institutional holders include Renaissance Technologies (RenTech) and Steven Cohen.

Institutional sentiment is currently Bullish. This is evidenced by a $10.97 M net inflow during the quarter.

Recent activity highlights Jefferies Group who opened a new position. Conversely, Mario Gabelli reduced exposure by 0.8%.

Key Holders

Top 5 by Value

Top 5 by Conviction

Recent Activity Breakdown (Q2 2026)

+$10.97 M
Total Buy Value
New Buys 2
Additions 3
-$3,633.76
Total Sell Value
Reductions 1
Sold Out 0

Guru Consensus (Q2 2026)

Based on recent activity
Net Sellers
1
Net Buyers
5

FAQs for Glaukos Corporation (GKOS)

Major holders include Renaissance Technologies (RenTech) ($20.57 M), Steven Cohen ($19.33 M), Cliff Asness ($2.29 M). According to the latest reported data, 6 tracked investment managers collectively hold approximately 316,297 shares.

According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $10.97 M, with 5 managers increasing positions and 1 managers reducing holdings.

During the most recent reporting period, 1 managers trimmed their positions, while 0 fully exited GKOS. The total reported sell value was $3,633.76.

Yes, 2 managers opened new positions in GKOS, and 3 increased their existing holdings. The total reported buy value was $10.97 M.

Portfolio Manager % Portfolio Activity Shares Value Report Date
0.03% Add 23.8% 147,192 $20.57 M Q2 2026
0.02% Add 36.5% 138,300 $19.33 M Q2 2026
0.00% Add 14.5% 16,401 $2.29 M Q2 2026
0.01% New Buy 7,856 $1.1 M Q2 2026
0.00% New Buy 3,310 $462,606 Q2 2026
0.00% Reduce -0.8% 3,238 $452,543 Q2 2026
Date
Insider Name
Transaction
Value
Shares
Position / Chg
SEC Form